![Mark Corrigan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Corrigan
Directeur/Membre du Conseil chez
WAVE LIFE SCIENCES LTD.
Fortune : - $ au 30/06/2026
Profil
Mark H.
N.
Corrigan was the founder of Tremeau Pharmaceuticals, Inc., founded in 2016, where the title held was President-Research & Development from 2016 to 2017.
Current jobs include Chairman at Exacis Biotherapeutics, Inc. since 2020; Independent Director at Wave Life Sciences Ltd. since 2019; Director at Wave Life Sciences USA, Inc. since 2019; Director at Perseus Holdings USA LLC since 2020; Scientific Advisor at Brighton Biotech, Inc.; and President at Silver Creek Pharmaceuticals, Inc. since 2024.
Former jobs include Chief Executive Officer & Director at Correvio Pharma Corp.
from 2019 to 2020; President & Chief Executive Officer at CombinatoRx, Inc. in 2010; President, Chief Executive Officer & Director at Zalicus, Inc. from 2011 to 2014; Chairman at EPIRUS Biopharmaceuticals, Inc. from 2014 to 2016; Executive Chairman at Novelion Therapeutics, Inc. from 2018 to 2019; Chairman at Elios Therapeutics LLC; Independent Director at Cubist Pharmaceuticals LLC from 2011 to 2015; Independent Director at Avanir Pharmaceuticals, Inc. from 2014 to 2015; Director at CoLucid Pharmaceuticals, Inc. from 2015 to 2017; Director at Synereca Pharmaceuticals, Inc.; Director at Neuromed Pharmaceuticals Ltd.; Lead Independent Director at BlackThorn Therapeutics, Inc. from 2018 to 2019; Director at Quartet Medicine, Inc.; Independent Director at Nabriva Therapeutics Plc from 2017 to 2020 and from 2021 to 2023; Independent Director at Trevena, Inc. from 2023 to 2024; Director at Pamlico BioPharma, Inc.; Group Vice President-Global Clinical Research at Pharmacia & Upjohn, Inc. from 1993 to 2003; Executive Vice President-Research & Development at Sumitomo Pharma America, Inc. from 2003 to 2009; Group Vice President-Global Clinical Research at Pharmacia Corp.
from 1998 to 2003; Member-Supervisory Board at Nabriva Therapeutics GmbH from 2016 to 2017; and Principal at UNC School of Medicine.
Education includes undergraduate and doctorate degrees from the University of Virginia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Mark Corrigan
| Sociétés | Poste | Début |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Directeur/Membre du Conseil | 04/09/2019 |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Directeur/Membre du Conseil | 01/09/2019 |
Exacis Biotherapeutics, Inc.
 Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Président | 01/08/2020 |
Perseus Holdings USA LLC
 Perseus Holdings USA LLC Electronics DistributorsDistribution Services Markets vaccine platform technology | Directeur/Membre du Conseil | 20/10/2020 |
Brighton Biotech, Inc.
 Brighton Biotech, Inc. BiotechnologyHealth Technology Provides medical research services which focuses on treating negative consequences of oxidative stress | Corporate Officer/Principal | - |
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel regenerative medicines which focus on treating cardiovascular disease | President | 12/02/2024 |
Anciens postes connus de Mark Corrigan
| Sociétés | Poste | Fin |
|---|---|---|
| TREVENA, INC. | Directeur/Membre du Conseil | 05/11/2024 |
| NABRIVA THERAPEUTICS PLC | Directeur/Membre du Conseil | 30/07/2023 |
| CORREVIO PHARMA CORP. | Directeur Général | 27/05/2020 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mark Corrigan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for commercializing cardiovascular hospital drugs | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Synereca Pharmaceuticals, Inc.
 Synereca Pharmaceuticals, Inc. Medical DistributorsDistribution Services Develops orally active drugs that restore the effectiveness of existing antibiotics | Distribution Services |
Brighton Biotech, Inc.
Brighton Biotech, Inc. BiotechnologyHealth Technology Provides medical research services which focuses on treating negative consequences of oxidative stress | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Neuromed Pharmaceuticals Ltd.
 Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Health Technology |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel regenerative medicines which focus on treating cardiovascular disease | Health Technology |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
EPIRUS Biopharmaceuticals, Inc.
 EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
Quartet Medicine, Inc.
 Quartet Medicine, Inc. BiotechnologyHealth Technology Develops treatments for chronic pain and inflammation | Health Technology |
Pamlico BioPharma, Inc.
 Pamlico BioPharma, Inc. BiotechnologyHealth Technology Provides antibody therapeutics services | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Utilities |
Perseus Holdings USA LLC
Perseus Holdings USA LLC Electronics DistributorsDistribution Services Markets vaccine platform technology | Distribution Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Elios Therapeutics LLC
 Elios Therapeutics LLC Medical/Nursing ServicesHealth Services Provides immunotherapy services | Health Services |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Health Technology |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Choisissez Zonebourse 
